Compare, Analyse Sun Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs MYLAN (US) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   MYLAN
EQUITY SHARE DATA
    SUN PHARMA
Mar-19
MYLAN
Dec-18
SUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6793,610-   
Low Rs3751,987-   
Sales per share (Unadj.) Rs121.11,660.9-  
Earnings per share (Unadj.) Rs13.445.1-  
Cash flow per share (Unadj.) Rs20.7356.1-  
Dividends per share (Unadj.) Rs2.750-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs172.61,796.8-  
Shares outstanding (eoy) m2,399.26514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.7 258.3%   
Avg P/E ratio x39.462.0 63.5%  
P/CF ratio (eoy) x25.57.9 324.3%  
Price / Book Value ratio x3.11.6 196.1%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m1,264,6501,439,636 87.8%   
No. of employees `00017.535.0 50.0%   
Total wages/salary Rs m59,6710-   
Avg. sales/employee Rs Th16,608.124,415.1 68.0%   
Avg. wages/employee Rs Th3,409.60-   
Avg. net profit/employee Rs Th1,833.8663.0 276.6%   
INCOME DATA
Net Sales Rs m290,659854,528 34.0%  
Other income Rs m10,2550-   
Total revenues Rs m300,914854,528 35.2%   
Gross profit Rs m63,076221,120 28.5%  
Depreciation Rs m17,533160,001 11.0%   
Interest Rs m5,55341,100 13.5%   
Profit before tax Rs m50,24620,019 251.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-12,1440-   
Tax Rs m6,009-3,185 -188.7%   
Profit after tax Rs m32,09323,204 138.3%  
Gross profit margin %21.725.9 83.9%  
Effective tax rate %12.0-15.9 -75.2%   
Net profit margin %11.02.7 406.6%  
BALANCE SHEET DATA
Current assets Rs m310,692477,168 65.1%   
Current liabilities Rs m173,396347,908 49.8%   
Net working cap to sales %47.215.1 312.3%  
Current ratio x1.81.4 130.6%  
Inventory Days Days9984 118.5%  
Debtors Days Days11293 119.6%  
Net fixed assets Rs m232,477165,764 140.2%   
Share capital Rs m2,399455 527.3%   
"Free" reserves Rs m411,6910-   
Net worth Rs m414,091924,444 44.8%   
Long term debt Rs m15,226997,771 1.5%   
Total assets Rs m646,9382,479,717 26.1%  
Interest coverage x10.01.5 675.8%   
Debt to equity ratio x01.1 3.4%  
Sales to assets ratio x0.40.3 130.4%   
Return on assets %5.82.6 224.4%  
Return on equity %7.82.5 308.8%  
Return on capital %10.23.2 319.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m27,4150-   
CASH FLOW
From Operations Rs m21,965177,571 12.4%  
From Investments Rs m-6,813-91,785 7.4%  
From Financial Activity Rs m-27,305-82,723 33.0%  
Net Cashflow Rs m-8,4421,471 -573.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 75.83 Rs / USD

Compare SUN PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: LUPIN  FULFORD INDIA  CIPLA  J.B.CHEMICALS  PFIZER  



Today's Market

Sensex Zooms 595 Points; Capital Goods, Automobile and Banking Stocks Rally(Closing)

Indian share markets continued their momentum during closing hours today and ended on a strong note.

Related Views On News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio (Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

How Commodity Prices Tell You When Stocks Will Go Up (Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

Which Stocks Should You Buy, Sell, and Hold in the Market Today? (Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

Get Rich as the
Market Rebounds from Covid-19

Coronavirus Rebound
Get this special guide, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


May 28, 2020 03:33 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE SUN PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS